An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.	Oligometastatic Prostate Cancer (OMPC)	Recruiting	Phase 3	2026-09-22		NCT05939414

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Novartis Pharmaceuticals	432

40 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Associated Med Professionals of NY	Syracuse	United States	4
BAMF Health	Grand Rapids	United States	15
Beth Israel Deaconess Med Ctr	Boston	United States	3
Blue Ridge Cancer Center	Wytheville	United States	2
Cancer Specialists of North Florida	Jacksonville	United States	24
Carolina Urologic Research Center	Myrtle Beach	United States	55
Dana Farber Cancer Institute	Boston	United States	133
Dayton Physicians	Kettering	United States	1
East Carolina University	Greenville	United States	24
East Jefferson Hospital	Metairie	United States	3
Highlands Oncology Group	Fayetteville	United States	16
Johns Hopkins Kimmel Com Cancer Ctr	Baltimore	United States	1
Mary Bird Perkins Cancer Center	Baton Rouge	United States	112
Mayo Clinic Rochester	Rochester	United States	133
Memorial Sloan Kettering Cancer Ctr	New York	United States	9
Montefiore Hospital	The Bronx	United States	1
Oregon Urology Institute	Springfield	United States	14
Piedmont Healthcare	Atlanta	United States	13
Profound Research LLC	Royal Oak	United States	2
Rio Grande Urology	El Paso	United States	5
Rocky Mountain Cancer Centers	Denver	United States	26
St Louis University	St Louis	United States	3
Stanford University	Palo Alto	United States	161
The Cancer Institute of Alexian Brothers	Elk Grove	United States	1
The Urology Center PC DBA UroHealth Partners	Omaha	United States	1

Clinical trials